Apathy syndrome in a patient previously treated with selective serotonin reuptake inhibitors for depression |
Kim, Hye-Geum
(Department of Psychiatry, Yeungnam University College of Medicine)
Koo, Bon-Hoon (Department of Psychiatry, Yeungnam University College of Medicine) Lee, Seung Woo (Department of Psychiatry, Yeungnam University College of Medicine) Cheon, Eun-Jin (Department of Psychiatry, Yeungnam University College of Medicine) |
1 | Marin RS. Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 1991;3:243-54. DOI |
2 | Barnhart WJ, Makela EH, Latocha MJ. SSRI-induced apathy syndrome: a clinical review. J Psychiatr Pract 2004;10:196-9. DOI |
3 | Starkstein SE, Jorge R, Mizrahi R, Robinson RG. A prospective longitudinal study of apathy in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2006;77:8-11. DOI |
4 | Padala PR, Burke WJ, Bhatia SC. Modafinil therapy for apathy in an elderly patient. Ann Pharmacother 2007;41:346-9. DOI |
5 | Roth RM, Flashman LA, McAllister TW. Apathy and its treatment. Curr Treat Options Neurol 2007;9:363-70. DOI |
6 | McPherson S, Fairbanks L, Tiken S, Cummings JL, Back-Madruga C. Apathy and executive function in Alzheimer's disease. J Int Neuropsychol Soc 2002;8:373-81. DOI |
7 | Wongpakaran N, van Reekum R, Wongpakaran T, Clarke D. Selective serotonin reuptake inhibitor use associates with apathy among depressed elderly: a case-control study. Ann Gen Psychiatry 2007;6:7. DOI |
8 | Dubini A, Bosc M, Polin V. Do noradrenaline and serotonin differentially affect social motivation and behaviour? Eur Neuropsychopharmacol 1997;7(Suppl 1): S49-55. DOI |
9 | Lanctot KL, Aguera-Ortiz L, Brodaty H, Francis PT, Geda YE, Ismail Z, et al. Apathy associated with neurocognitive disorders: Recent progress and future directions. Alzheimers Dement 2017;13:84-100. DOI |
10 | Galynker I, Ieronimo C, Miner C, Rosenblum J, Vilkas N, Rosenthal R. Methylphenidate treatment of negative symptoms in patients with dementia. J Neuropsychiatry Clin Neurosci 1997;9:231-9. DOI |
11 | van Reekum R, Bayley M, Garner S, Burke IM, Fawcett S, Hart A, et al. N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury. Brain Inj 1995;9:49-53. DOI |
12 | Marin RS, Fogel BS, Hawkins J, Duffy J, Krupp B. Apathy: a treatable syndrome. J Neuropsychiatry Clin Neurosci 1995;7:23-30. DOI |
13 | Debette S, Kozlowski O, Steinling M, Rousseaux M. Levodopa and bromocriptine in hypoxic brain injury. J Neurol 2002;249:1678-82. DOI |
14 | Newburn G, Newburn D. Selegiline in the management of apathy following traumatic brain injury. Brain Inj 2005;19:149-54. DOI |
15 | Corcoran C, Wong ML, O'Keane V. Bupropion in the management of apathy. J Psychopharmacol 2004;18:133-5. DOI |
16 | Holmes C, Wilkinson D, Dean C, Vethanayagam S, Olivieri S, Langley A, et al. The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease. Neurology 2004;63:214-9. DOI |
17 | Zhang N, Wei C, Du H, Shi FD, Cheng Y. The effect of memantine on cognitive function and behavioral and psychological symptoms in mild-to-moderate Alzheimer's disease patients. Dement Geriatr Cogn Disord 2015;40:85-93. DOI |
18 | Gerrard P, Malcolm R. Mechanisms of modafinil: a review of current research. Neuropsychiatr Dis Treat 2007;3:349-64. |
19 | Camargos EF, Quintas JL. Apathy syndrome treated successfully with modafinil. BMJ Case Rep 2011;2011:pii: bcr0820114652. |
20 | Marangell LB, Johnson CR, Kertz B, Zboyan HA, Martinez JM. Olanzapine in the treatment of apathy in previously depressed participants maintained with selective serotonin reuptake inhibitors: an open-label, flexible-dose study. J Clin Psychiatry 2002;63:391-5. DOI |